|
|
Management of Mycoplasmas - A Seminar on Prevention, Control and Detection
 | Registration is now open for this one day seminar on the 'Prevention, Control and Detection of Mollicutes in Pharmaceutical Processes,' 15 May 2008, Eastwood Hall, Nottingham, that is hosted by Oxoid, Millipore and Mycoplasma Experience.
Chaired by Robin Nicholas, Leader of the Mycoplasma Group, at the Veterinary Laboratories Agency (Weybridge, UK), the seminar provides vital insights and current thinking on mycoplasmas, best practice in detection and filtration, aspects applicable to media fill trials, and the impact of regulation on testing.
|
The agenda topics and speakers are:
- Detection of Mollicutes using NAT/PCR Methods - Sandra Jainandunsing, Manager Method Development & Validation, Millipore
- Filtration Technology as a Solution to Reduce the Risk of Mycoplasma Contamination in Biotech Processes - Joachim Regel, European Technology Manager for Aseptic Processing, Millipore
- Acholeplasma laidlawii, the Hidden Menace - Helena Windsor, Director, Mycoplasma Experience
- Changes to Aseptic Filling Validations and the Impact on Media - Alison Smith, Pharmaceutical Marketing Manager, Thermo Fisher Scientific
- Regulatory Aspects of Mycoplasma Testing - Steve Spencer, Immunologicals Assessor, Veterinary Medicines Directorate
The seminar cost is £50 plus VAT per delegate which includes morning coffee, lunch and afternoon tea; accommodation and travel are not included in the seminar fee.
To book your place, please use the email address at the top of this page for a copy of the Seminar Booking form, or telephone Val Kane, Oxoid on +44 (0)1256 694238. Alternatively send a cheque for £58.75, made payable to Oxoid Ltd, and your contact details, by post to: Alison Smith, Pharmaceutical Marketing Manager, Oxoid, Wade Road, Basingstoke, Hants RG24 8PW, UK.
Chair and Speakers' Biographies:
Robin Nicholas, Leader of the Mycoplasma Group, at the Veterinary Laboratories Agency (Weybridge).Robin is a member of the FAO and EU groups of experts on contagious bovine pleuropneumoniae. He has been a member of the Mycoplasma Expert Group for the European Pharmacopoeia since 2000 and was appointed Mycoplasma Advisor to the EU expert on the VICH Expert Working Group on biologicals in 2006.
Sandra Jainandunsing, Manager Method Development & Validation, MicroSafe. Sandra has set up the new molecular biology unit within Millipore's MicroSafe Services. One of the first assays to be validated and transferred to routine operation was Nucleic Acid Technology (NAT) testing for mollicutes according to the EP. Future NAT projects are: quantitation of mollicutes, residual DNA and DNA fingerprinting.
Joachim Regel is European Technology Manager for Aseptic Processing covering the European market for Millipore, based in Molsheim (France). He has 15 years experience in filtration & separation technologies, 10 years of this in the pharmaceutical industry. He has been involved in many pharmaceutical projects including consultation for aspects of design, implementation and validation of sterilizing filtration systems in aseptic processing. Millipore is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Advancing Life Science Together™.
Helena Windsor, Director, Mycoplasma Experience. Helena is a member of the PDA Mycoplasma Working Party and of the International Organisation for Mycoplasmology where she is currently team leader of the cell culture/diagnostics team of the International Research Program on Comparative Mycoplasmology. Mycoplasma Experience specialises in the culture of mollicutes and supplies testing services and high quality culture media to the biotech industry.
Alison Smith, Pharmaceutical Marketing Manager, Oxoid Ltd. Alison is a member of the Parenteral Drug Association Mycoplasma Working Party. Oxoid is the world leading brand in pharmaceutical microbiology and part of Thermo Fisher Scientific.
Steve Spencer, Immunologicals Assessor, Veterinary Medicines Directorate. Steve is a member of the Immunologicals team at the VMD, responsible for the assessment of applications from manufacturers of veterinary immunological products for UK Marketing Authorisations.
| |
Source: Oxoid Ltd.
Posted: March 31, 2008
|
|
|
|
